Kevin DAmour

Insider Reports History

Entity
Individual
Location
C/O Brooklyn Immunotherapeutics, Inc., 140 58 Th Street, Building A, Suite 2100, Brooklyn, NY
Signature
/s/ Kevin D'Amour
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin DAmour:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Brooklyn ImmunoTherapeutics, Inc. Chief Scientific Officer Restricted Stock Units 52.7K $131K $2.48 Jun 28, 2022 Direct
Brooklyn ImmunoTherapeutics, Inc. Chief Scientific Officer Common Stock 11.5K $28.5K $2.48 Jun 28, 2022 Direct

Insider Reports Filed by Kevin DAmour

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ERNA Brooklyn ImmunoTherapeutics, Inc. Jun 28, 2022 3 -$3.36K 4 Jun 29, 2022 Chief Scientific Officer
ERNA Brooklyn ImmunoTherapeutics, Inc. Mar 11, 2022 1 $0 4/A Mar 17, 2022 Chief Scientific Officer
ERNA Brooklyn ImmunoTherapeutics, Inc. Jun 28, 2021 2 $0 4 Jun 30, 2021 Chief Scientific Officer
ERNA Brooklyn ImmunoTherapeutics, Inc. Jun 28, 2021 0 $0 3 Jun 30, 2021 Chief Scientific Officer. Exhibit List: Exhibit 24 - Power of Attorney